Skip to main content
BTC / USDT107,400+2.19%ETH / USDT3,840+2.13%SOL / USDT182.40−1.99%BNB / USDT652.30+0.66%XRP / USDT2.2150+1.61%DOGE / USDT0.3850−1.79%TON / USDT5.240+2.34%AVAX / USDT42.60−2.07%LINK / USDT22.40+2.28%ADA / USDT1.0520−1.68%TRX / USDT0.3300+0.92%DOT / USDT8.420+2.93%BTC / USDT107,400+2.19%ETH / USDT3,840+2.13%SOL / USDT182.40−1.99%BNB / USDT652.30+0.66%XRP / USDT2.2150+1.61%DOGE / USDT0.3850−1.79%TON / USDT5.240+2.34%AVAX / USDT42.60−2.07%LINK / USDT22.40+2.28%ADA / USDT1.0520−1.68%TRX / USDT0.3300+0.92%DOT / USDT8.420+2.93%
stocksJul 29, 2026, 11:18 AM

P&G Q4 Earnings Beat on EPS but Sales Miss; Guidance In Line

Procter & Gamble reported quarterly core EPS of $1.43, topping estimates, but net sales of $21.20B fell short. Full-year guidance was broadly in line with expectations.

PG

Procter & Gamble (PG) released mixed fourth‑quarter results. Core earnings per share came in at $1.43, beating the consensus estimate of $1.41. However, net sales of $21.20 billion missed the $21.34 billion Wall Street expected.

Organic sales performance varied across divisions. Beauty organic sales rose 4%, slightly below the 4.2% forecast, while the Baby, Feminine & Family Care segment saw a 2% decline versus an estimated 0.7% increase. Grooming organic sales estimates were 1.45% growth.

The company provided its fiscal 2027 outlook. It sees core EPS growth of 0% to 3%, implying a range of $6.89 to $7.11 compared with the $7.02 analyst consensus. Organic revenue is projected to increase 1% to 3%, against an estimate of 2.44%.

Source: First Squawk